Clinicians rate patients with lung cancer with poorer quality of life
11/05/2013
Advances have been made in the treatment of lung cancer, but the disease continues to be a challenge to treat, primarily because of a high number of people who have late-stage cancer at the time of diagnosis, the likelihood of poor outcomes, and a greater symptom burden...
At the 44th Union World Conference on Lung Health in Paris, members of the International Union Against Tuberculosis and Lung Health (The Union) issued a warning about the potential health impact of e-cigarettes and electronic nicotine delivery systems (ENDS) and called for urgent regulation of these products...
International trauma project set to reduce fatalities
11/05/2013
Several of the world's most renowned trauma teams, including Queen Mary University of London in partnership with The Royal London Hospital, are embarking on an extensive five-year project to investigate abnormal bleeding in trauma patients. The project, which has just begun, will aim to develop international guidelines to treat abnormal bleeding (known as coagulopathy) in trauma patients...
Liver tropism is key for B cell deletion immunotherapy
11/05/2013
Antibodies against the B cell surface protein CD20 have been used successfully to treat B cell-mediated autoimmune diseases and lymphomas. Antibody binding receptors, called Fc receptors, on other immune cells bind anti-CD20 on coated B cells, which induces B cell deletion through a mechanism that is not clearly understood...
Promising results from experimental drug for treating the most common form of lung cancer
11/05/2013
An experimental cancer drug that has shown promise in the treatment of melanoma has also shown early potential as an effective treatment for patients with non-small cell lung cancer, the leading cause of cancer death among men and women worldwide. Dr...
Efforts to address cervical cancer hindered by leadership void, not lack of money
11/05/2013
A study by Indiana University public health researchers found that the opportunity for significant progress in addressing cervical cancer across the country is being squandered -- not because of a lack of money, but because of a void of leadership and organization at the state levels...
Cancer is a health burden of increasing importance which affects close to 13 million people globally. Bone is often affected in these patients, frequently because of bone metastases, or as a result of anti-cancer therapies which can contribute to bone loss and fragility...
Combination therapy could treat common children's cancer
11/05/2013
A dual-pronged strategy using two experimental cancer drugs together could successfully treat a childhood cancer by inhibiting tumour growth and blocking off the escape routes it uses to become resistant to treatment, finds a new study...
Genetic profiling identifies heart attack patients resistant to blood thinners
11/05/2013
Results of the GIANT trial reported at TCT 2013 According to a new study, genetic profiling of patients undergoing percutaneous coronary intervention (PCI) may help cardiology teams adjust treatment and improve ischemic outcomes for patients that do not properly metabolize thienopyridine blood thinning therapies such as clopidogrel...
Removing blood clots during PCI not found to improve outcomes
11/05/2013
Results of the TATORT-NSTEMI trial presented at TCT 2013 According to a new study, aspirating blood clots does not significantly reduce microvascular obstruction or reduce the risk of death in patients with non-ST-elevation myocardial infarction (NSTEMI), when compared to standard percutaneous coronary intervention (PCI) without thrombectomy...